{"id": "179625", "url": "https://fevir.net/resources/Citation/179625", "meta": {"profile": ["http://hl7.org/fhir/uv/ebm/StructureDefinition/journal-article-citation"], "versionId": "18", "lastUpdated": "2025-10-13T12:34:35.118Z"}, "title": "22502942 Addition of radiotherapy to long-term androgen deprivation in locally advanced prostate cancer: an open randomised phase 3 trial.", "author": [{"name": "Computable Publishing\u00ae: MEDLINE-to-FEvIR Converter"}], "status": "active", "contact": [{"telecom": [{"value": "support@computablepublishing.com", "system": "email"}]}], "contained": [{"id": "contributor0", "name": [{"given": ["Nicolas"], "family": "Mottet"}], "resourceType": "Practitioner"}, {"id": "contributor1", "name": [{"given": ["Michel"], "family": "Peneau"}], "resourceType": "Practitioner"}, {"id": "contributor2", "name": [{"given": ["Jean-Jacques"], "family": "Mazeron"}], "resourceType": "Practitioner"}, {"id": "contributor3", "name": [{"given": ["Vincent"], "family": "Molinie"}], "resourceType": "Practitioner"}, {"id": "contributor4", "name": [{"given": ["Pierre"], "family": "Richaud"}], "resourceType": "Practitioner"}, {"id": "meshHeading0", "content": [{"type": {"text": "components (if present) include qualifier codings", "coding": [{"code": "mesh-heading", "system": "http://terminology.hl7.org/CodeSystem/cited-artifact-classification-type", "display": "MeSH heading"}]}, "component": [{"type": {"text": "qualifier"}, "classifier": [{"text": "is not a major topic"}]}, {"type": {"text": "qualifier"}, "component": [{"type": {"text": "is Major topic"}, "classifier": [{"coding": [{"code": "C49487", "system": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl", "display": "No"}]}]}], "classifier": [{"coding": [{"code": "Q000188", "system": "https://www.nlm.nih.gov/mesh", "display": "drug therapy"}]}]}, {"type": {"text": "qualifier"}, "component": [{"type": {"text": "is Major topic"}, "classifier": [{"coding": [{"code": "C49487", "system": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl", "display": "No"}]}]}], "classifier": [{"coding": [{"code": "Q000532", "system": "https://www.nlm.nih.gov/mesh", "display": "radiotherapy"}]}]}, {"type": {"text": "qualifier"}, "component": [{"type": {"text": "is Major topic"}, "classifier": [{"coding": [{"code": "C49488", "system": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl", "display": "Yes"}]}]}], "classifier": [{"coding": [{"code": "Q000628", "system": "https://www.nlm.nih.gov/mesh", "display": "therapy"}]}]}], "classifier": [{"coding": [{"code": "D000230", "system": "https://www.nlm.nih.gov/mesh", "display": "Adenocarcinoma", "userSelected": false}]}], "freeToShare": true}, {"type": {"text": "components (if present) include qualifier codings", "coding": [{"code": "mesh-heading", "system": "http://terminology.hl7.org/CodeSystem/cited-artifact-classification-type", "display": "MeSH heading"}]}, "component": [{"type": {"text": "qualifier"}, "classifier": [{"text": "is not a major topic"}]}], "classifier": [{"coding": [{"code": "D000368", "system": "https://www.nlm.nih.gov/mesh", "display": "Aged", "userSelected": false}]}], "freeToShare": true}, {"type": {"text": "components (if present) include qualifier codings", "coding": [{"code": "mesh-heading", "system": "http://terminology.hl7.org/CodeSystem/cited-artifact-classification-type", "display": "MeSH heading"}]}, "component": [{"type": {"text": "qualifier"}, "classifier": [{"text": "is not a major topic"}]}, {"type": {"text": "qualifier"}, "component": [{"type": {"text": "is Major topic"}, "classifier": [{"coding": [{"code": "C49487", "system": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl", "display": "No"}]}]}], "classifier": [{"coding": [{"code": "Q000627", "system": "https://www.nlm.nih.gov/mesh", "display": "therapeutic use"}]}]}], "classifier": [{"coding": [{"code": "D000726", "system": "https://www.nlm.nih.gov/mesh", "display": "Androgen Antagonists", "userSelected": false}]}], "freeToShare": true}, {"type": {"text": "components (if present) include qualifier codings", "coding": [{"code": "mesh-heading", "system": "http://terminology.hl7.org/CodeSystem/cited-artifact-classification-type", "display": "MeSH heading"}]}, "component": [{"type": {"text": "qualifier"}, "classifier": [{"text": "is not a major topic"}]}, {"type": {"text": "qualifier"}, "component": [{"type": {"text": "is Major topic"}, "classifier": [{"coding": [{"code": "C49488", "system": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl", "display": "Yes"}]}]}], "classifier": [{"coding": [{"code": "Q000627", "system": "https://www.nlm.nih.gov/mesh", "display": "therapeutic use"}]}]}], "classifier": [{"coding": [{"code": "D018931", "system": "https://www.nlm.nih.gov/mesh", "display": "Antineoplastic Agents, Hormonal", "userSelected": false}]}], "freeToShare": true}, {"type": {"text": "components (if present) include qualifier codings", "coding": [{"code": "mesh-heading", "system": "http://terminology.hl7.org/CodeSystem/cited-artifact-classification-type", "display": "MeSH heading"}]}, "component": [{"type": {"text": "qualifier"}, "classifier": [{"text": "is not a major topic"}]}], "classifier": [{"coding": [{"code": "D059248", "system": "https://www.nlm.nih.gov/mesh", "display": "Chemoradiotherapy", "userSelected": false}]}], "freeToShare": true}, {"type": {"text": "components (if present) include qualifier codings", "coding": [{"code": "mesh-heading", "system": "http://terminology.hl7.org/CodeSystem/cited-artifact-classification-type", "display": "MeSH heading"}]}, "component": [{"type": {"text": "qualifier"}, "classifier": [{"text": "is not a major topic"}]}], "classifier": [{"coding": [{"code": "D018572", "system": "https://www.nlm.nih.gov/mesh", "display": "Disease-Free Survival", "userSelected": false}]}], "freeToShare": true}, {"type": {"text": "components (if present) include qualifier codings", "coding": [{"code": "mesh-heading", "system": "http://terminology.hl7.org/CodeSystem/cited-artifact-classification-type", "display": "MeSH heading"}]}, "component": [{"type": {"text": "qualifier"}, "classifier": [{"text": "is not a major topic"}]}], "classifier": [{"coding": [{"code": "D004359", "system": "https://www.nlm.nih.gov/mesh", "display": "Drug Therapy, Combination", "userSelected": false}]}], "freeToShare": true}, {"type": {"text": "components (if present) include qualifier codings", "coding": [{"code": "mesh-heading", "system": "http://terminology.hl7.org/CodeSystem/cited-artifact-classification-type", "display": "MeSH heading"}]}, "component": [{"type": {"text": "qualifier"}, "classifier": [{"text": "is not a major topic"}]}, {"type": {"text": "qualifier"}, "component": [{"type": {"text": "is Major topic"}, "classifier": [{"coding": [{"code": "C49488", "system": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl", "display": "Yes"}]}]}], "classifier": [{"coding": [{"code": "Q000627", "system": "https://www.nlm.nih.gov/mesh", "display": "therapeutic use"}]}]}], "classifier": [{"coding": [{"code": "D005485", "system": "https://www.nlm.nih.gov/mesh", "display": "Flutamide", "userSelected": false}]}], "freeToShare": true}, {"type": {"text": "components (if present) include qualifier codings", "coding": [{"code": "mesh-heading", "system": "http://terminology.hl7.org/CodeSystem/cited-artifact-classification-type", "display": "MeSH heading"}]}, "component": [{"type": {"text": "qualifier"}, "classifier": [{"text": "is not a major topic"}]}], "classifier": [{"coding": [{"code": "D006801", "system": "https://www.nlm.nih.gov/mesh", "display": "Humans", "userSelected": false}]}], "freeToShare": true}, {"type": {"text": "components (if present) include qualifier codings", "coding": [{"code": "mesh-heading", "system": "http://terminology.hl7.org/CodeSystem/cited-artifact-classification-type", "display": "MeSH heading"}]}, "component": [{"type": {"text": "qualifier"}, "classifier": [{"text": "is not a major topic"}]}, {"type": {"text": "qualifier"}, "component": [{"type": {"text": "is Major topic"}, "classifier": [{"coding": [{"code": "C49488", "system": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl", "display": "Yes"}]}]}], "classifier": [{"coding": [{"code": "Q000627", "system": "https://www.nlm.nih.gov/mesh", "display": "therapeutic use"}]}]}], "classifier": [{"coding": [{"code": "D016729", "system": "https://www.nlm.nih.gov/mesh", "display": "Leuprolide", "userSelected": false}]}], "freeToShare": true}, {"type": {"text": "components (if present) include qualifier codings", "coding": [{"code": "mesh-heading", "system": "http://terminology.hl7.org/CodeSystem/cited-artifact-classification-type", "display": "MeSH heading"}]}, "component": [{"type": {"text": "qualifier"}, "classifier": [{"text": "is not a major topic"}]}], "classifier": [{"coding": [{"code": "D008297", "system": "https://www.nlm.nih.gov/mesh", "display": "Male", "userSelected": false}]}], "freeToShare": true}, {"type": {"text": "components (if present) include qualifier codings", "coding": [{"code": "mesh-heading", "system": "http://terminology.hl7.org/CodeSystem/cited-artifact-classification-type", "display": "MeSH heading"}]}, "component": [{"type": {"text": "qualifier"}, "classifier": [{"text": "is not a major topic"}]}], "classifier": [{"coding": [{"code": "D008875", "system": "https://www.nlm.nih.gov/mesh", "display": "Middle Aged", "userSelected": false}]}], "freeToShare": true}, {"type": {"text": "components (if present) include qualifier codings", "coding": [{"code": "mesh-heading", "system": "http://terminology.hl7.org/CodeSystem/cited-artifact-classification-type", "display": "MeSH heading"}]}, "component": [{"type": {"text": "qualifier"}, "classifier": [{"text": "is not a major topic"}]}], "classifier": [{"coding": [{"code": "D060787", "system": "https://www.nlm.nih.gov/mesh", "display": "Neoplasm Grading", "userSelected": false}]}], "freeToShare": true}, {"type": {"text": "components (if present) include qualifier codings", "coding": [{"code": "mesh-heading", "system": "http://terminology.hl7.org/CodeSystem/cited-artifact-classification-type", "display": "MeSH heading"}]}, "component": [{"type": {"text": "qualifier"}, "classifier": [{"text": "is not a major topic"}]}, {"type": {"text": "qualifier"}, "component": [{"type": {"text": "is Major topic"}, "classifier": [{"coding": [{"code": "C49487", "system": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl", "display": "No"}]}]}], "classifier": [{"coding": [{"code": "Q000097", "system": "https://www.nlm.nih.gov/mesh", "display": "blood"}]}]}], "classifier": [{"coding": [{"code": "D017430", "system": "https://www.nlm.nih.gov/mesh", "display": "Prostate-Specific Antigen", "userSelected": false}]}], "freeToShare": true}, {"type": {"text": "components (if present) include qualifier codings", "coding": [{"code": "mesh-heading", "system": "http://terminology.hl7.org/CodeSystem/cited-artifact-classification-type", "display": "MeSH heading"}]}, "component": [{"type": {"text": "qualifier"}, "classifier": [{"text": "is not a major topic"}]}, {"type": {"text": "qualifier"}, "component": [{"type": {"text": "is Major topic"}, "classifier": [{"coding": [{"code": "C49487", "system": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl", "display": "No"}]}]}], "classifier": [{"coding": [{"code": "Q000188", "system": "https://www.nlm.nih.gov/mesh", "display": "drug therapy"}]}]}, {"type": {"text": "qualifier"}, "component": [{"type": {"text": "is Major topic"}, "classifier": [{"coding": [{"code": "C49487", "system": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl", "display": "No"}]}]}], "classifier": [{"coding": [{"code": "Q000532", "system": "https://www.nlm.nih.gov/mesh", "display": "radiotherapy"}]}]}, {"type": {"text": "qualifier"}, "component": [{"type": {"text": "is Major topic"}, "classifier": [{"coding": [{"code": "C49488", "system": "http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl", "display": "Yes"}]}]}], "classifier": [{"coding": [{"code": "Q000628", "system": "https://www.nlm.nih.gov/mesh", "display": "therapy"}]}]}], "classifier": [{"coding": [{"code": "D011471", "system": "https://www.nlm.nih.gov/mesh", "display": "Prostatic Neoplasms", "userSelected": false}]}], "freeToShare": true}], "resourceType": "ArtifactAssessment", "artifactReference": {"type": "Citation", "reference": "#"}}], "copyright": "https://creativecommons.org/licenses/by-nc-sa/4.0/", "extension": [{"url": "http://hl7.org/fhir/uv/ebm/StructureDefinition/artifact-publication-status", "valueCodeableConcept": {"coding": [{"code": "active", "system": "http://terminology.hl7.org/CodeSystem/cited-artifact-status-type", "display": "Active"}]}}], "publisher": "Computable Publishing LLC", "identifier": [{"type": {"text": "FEvIR Object Identifier", "coding": [{"system": "http://terminology.hl7.org/CodeSystem/v2-0203", "code": "ACSN", "display": "Accession ID"}]}, "value": "179625", "system": "https://fevir.net/FOI", "assigner": {"display": "Computable Publishing LLC"}}, {"value": "22502942", "system": "https://pubmed.ncbi.nlm.nih.gov"}], "statusDate": [{"period": {"end": "2012-02-03"}, "activity": {"coding": [{"code": "pubmed-pubstatus-received", "system": "http://hl7.org/fhir/citation-status-type", "display": "PubMed Pubstatus of Received"}]}}, {"period": {"end": "2012-03-23"}, "activity": {"coding": [{"code": "pubmed-pubstatus-accepted", "system": "http://hl7.org/fhir/citation-status-type", "display": "PubMed Pubstatus of Accepted"}]}}, {"period": {"end": "2012-04-17T06:00:00.000Z"}, "activity": {"coding": [{"code": "pubmed-pubstatus-entrez", "system": "http://hl7.org/fhir/citation-status-type", "display": "PubMed Pubstatus of Entrez"}]}}, {"period": {"end": "2012-04-17T06:00:00.000Z"}, "activity": {"coding": [{"code": "pubmed-pubstatus-pubmed", "system": "http://hl7.org/fhir/citation-status-type", "display": "PubMed Pubstatus of Pubmed"}]}}, {"period": {"end": "2012-12-12T06:00:00.000Z"}, "activity": {"coding": [{"code": "pubmed-pubstatus-medline", "system": "http://hl7.org/fhir/citation-status-type", "display": "PubMed Pubstatus of Medline"}]}}], "useContext": [{"code": {"code": "fevir-platform-use", "system": "http://terminology.hl7.org/CodeSystem/citation-classification-type", "display": "FEvIR Platform Use"}, "valueCodeableConcept": {"coding": [{"code": "medline-base", "system": "http://terminology.hl7.org/CodeSystem/citation-artifact-classifier", "display": "Medline Base", "userSelected": false}]}}], "approvalDate": "2012-12-07", "currentState": [{"coding": [{"code": "medline-medline", "system": "http://hl7.org/fhir/citation-status-type", "display": "Medline Citation Status of Medline"}]}, {"coding": [{"code": "pubmed-publication-status-ppublish", "system": "http://hl7.org/fhir/citation-status-type", "display": "PubMed PublicationStatus of ppublish"}]}], "resourceType": "Citation", "citedArtifact": {"title": [{"text": "Addition of radiotherapy to long-term androgen deprivation in locally advanced prostate cancer: an open randomised phase 3 trial.", "type": [{"coding": [{"code": "primary", "system": "http://terminology.hl7.org/CodeSystem/title-type", "display": "Primary title"}]}], "language": {"coding": [{"system": "urn:ietf:bcp:47", "code": "en", "display": "English"}]}}], "abstract": [{"text": "**BACKGROUND:** Radiotherapy combined with androgen-deprivation therapy (ADT) is superior to radiotherapy alone in localised prostate cancer; however, data comparing ADT alone are somewhat limited.\n**OBJECTIVE:** To compare 3-yr ADT plus radiotherapy with ADT alone in locally advanced prostate cancer patients.\n**DESIGN, SETTING, AND PARTICIPANTS:** A multicentre randomised open controlled phase 3 trial in 264 histologically confirmed T3-4 or pT3N0M0 prostate cancer patients randomised from March 2000 to December 2003.\n**INTERVENTION:** ADT (11.25mg subcutaneous depot injection of leuprorelin every 3 mo for 3 yr) plus external-beam radiotherapy or ADT alone. Flutamide (750 g/d) was administered for 1 mo.\n**OUTCOME MEASUREMENTS AND STATISTICAL ANALYSIS:** The primary objective was 5 yr progression-free survival (PFS) according to clinical or biologic criteria, using the American Society for Therapeutic Radiology and Oncology (ASTRO) and the newer (Phoenix) definition (nadir plus 2 ng/ml), by intention to treat. Secondary objectives included time to locoregional recurrence and distant metastases, and overall and disease-specific survival. Our Analyses: intent-to-treat analysis, multivariate analyses using a Cox model with a 5% threshold from univariate analysis, and Kaplan-Meier estimates.\n**RESULTS AND LIMITATIONS:** ADT alone was administered to 130 patients and combined therapy to 133. With a median follow-up of 67 mo, 5-yr PFS was 60.9% for combined therapy versus 8.5% with ADT alone (ASTRO; p&lt;0.0001), and 64.7% versus 15.4%, respectively, for Phoenix (p&lt;0.0011). Locoregional progression was reported in 9.8% of combined-therapy patients versus 29.2% with ADT alone (p&lt;0.0001) and metastatic progression in 3.0% versus 10.8%, respectively (p&lt;0.018). Overall survival was 71.4% with combined therapy versus 71.5% with ADT alone; disease-specific survival was 93.2% versus 86.2%. Limitations included the relatively small population and a relatively short follow-up period.\n**CONCLUSIONS:** Combined therapy strongly favoured improved PFS, locoregional control, and metastasis-free survival. Longer follow-up is needed to assess the potential survival impact.", "type": {"coding": [{"code": "primary-human-use", "system": "http://terminology.hl7.org/CodeSystem/cited-artifact-abstract-type", "display": "Primary human use"}]}, "copyright": "Copyright \u00a9 2012 European Association of Urology. Published by Elsevier B.V. All rights reserved."}], "relatesTo": [{"type": "comment-in", "citation": "Eur Urol. 2012 Aug;62(2):220-1; author reply 222-3. doi: 10.1016/j.eururo.2012.04.040.", "classifier": [{"coding": [{"code": "D016420", "system": "https://www.nlm.nih.gov/mesh", "display": "Comment", "userSelected": false}]}], "targetReference": {"reference": "https://pubmed.ncbi.nlm.nih.gov/22552217/", "identifier": {"value": "22552217", "system": "https://pubmed.ncbi.nlm.nih.gov", "assigner": {"display": "NLM"}}}}], "identifier": [{"value": "22502942", "system": "https://pubmed.ncbi.nlm.nih.gov"}, {"value": "10.1016/j.eururo.2012.03.053", "system": "https://doi.org"}, {"type": {"text": "pii", "coding": [{"system": "http://terminology.hl7.org/CodeSystem/v2-0203", "code": "ACSN", "display": "Accession ID"}]}, "value": "S0302-2838(12)00425-3"}], "webLocation": [{"url": "https://pubmed.ncbi.nlm.nih.gov/22502942/", "classifier": [{"coding": [{"code": "abstract", "system": "http://terminology.hl7.org/CodeSystem/artifact-url-classifier", "display": "Abstract"}]}]}, {"url": "https://doi.org/10.1016/j.eururo.2012.03.053", "classifier": [{"coding": [{"code": "doi-based", "system": "http://terminology.hl7.org/CodeSystem/artifact-url-classifier", "display": "DOI Based"}]}]}], "classification": [{"type": {"coding": [{"code": "publishing-model", "system": "http://terminology.hl7.org/CodeSystem/cited-artifact-classification-type", "display": "Publishing Model", "userSelected": false}]}, "classifier": [{"coding": [{"code": "Print-Electronic", "system": "http://terminology.hl7.org/CodeSystem/citation-artifact-classifier", "display": "Print Electronic", "userSelected": false}]}]}, {"type": {"coding": [{"code": "chemical", "system": "http://terminology.hl7.org/CodeSystem/cited-artifact-classification-type", "display": "Chemical", "userSelected": false}]}, "classifier": [{"coding": [{"code": "D000726", "system": "https://www.nlm.nih.gov/mesh", "display": "Androgen Antagonists", "userSelected": false}]}, {"coding": [{"code": "D018931", "system": "https://www.nlm.nih.gov/mesh", "display": "Antineoplastic Agents, Hormonal", "userSelected": false}]}, {"coding": [{"code": "76W6J0943E", "system": "https://www.cas.org/support/documentation/chemical-substances", "userSelected": false}, {"code": "D005485", "system": "https://www.nlm.nih.gov/mesh", "display": "Flutamide", "userSelected": false}]}, {"coding": [{"code": "EC 3.4.21.77", "system": "https://www.cas.org/support/documentation/chemical-substances", "userSelected": false}, {"code": "D017430", "system": "https://www.nlm.nih.gov/mesh", "display": "Prostate-Specific Antigen", "userSelected": false}]}, {"coding": [{"code": "EFY6W0M8TG", "system": "https://www.cas.org/support/documentation/chemical-substances", "userSelected": false}, {"code": "D016729", "system": "https://www.nlm.nih.gov/mesh", "display": "Leuprolide", "userSelected": false}]}]}, {"type": {"coding": [{"code": "mesh-heading", "system": "http://terminology.hl7.org/CodeSystem/cited-artifact-classification-type", "display": "MeSH heading"}]}, "artifactAssessment": [{"type": "ArtifactAssessment", "reference": "#meshHeading0"}]}, {"type": {"coding": [{"code": "publication-type", "system": "http://terminology.hl7.org/CodeSystem/cited-artifact-classification-type", "display": "Publication type"}]}, "classifier": [{"coding": [{"code": "D017428", "system": "https://www.nlm.nih.gov/mesh", "display": "Clinical Trial, Phase III", "userSelected": false}]}, {"coding": [{"code": "D016428", "system": "https://www.nlm.nih.gov/mesh", "display": "Journal Article", "userSelected": false}]}, {"coding": [{"code": "D016448", "system": "https://www.nlm.nih.gov/mesh", "display": "Multicenter Study", "userSelected": false}]}, {"coding": [{"code": "D016449", "system": "https://www.nlm.nih.gov/mesh", "display": "Randomized Controlled Trial", "userSelected": false}]}, {"coding": [{"code": "D013485", "system": "https://www.nlm.nih.gov/mesh", "display": "Research Support, Non-U.S. Gov't", "userSelected": false}]}]}, {"type": {"coding": [{"code": "knowledge-artifact-type", "system": "http://terminology.hl7.org/CodeSystem/cited-artifact-classification-type", "display": "Knowledge Artifact Type", "userSelected": false}]}, "classifier": [{"coding": [{"code": "D016428", "system": "http://terminology.hl7.org/CodeSystem/citation-artifact-classifier", "display": "Journal Article", "userSelected": false}]}], "artifactAssessment": [{"display": "Classifier added by Computable Publishing LLC"}]}, {"type": {"coding": [{"code": "citation-subset", "system": "http://terminology.hl7.org/CodeSystem/cited-artifact-classification-type", "display": "Citation subset", "userSelected": false}]}, "classifier": [{"coding": [{"code": "IM", "system": "https://www.nlm.nih.gov/bsd/licensee/elements_descriptions.html#citationsubset", "display": "IM", "userSelected": false}]}]}], "contributorship": {"entry": [{"affiliation": [{"display": "Department of Urology, University Hospital, St. Etienne, France. nicolas.mottet@wanadoo.fr"}], "contributor": {"type": "Practitioner", "display": "Mottet N", "reference": "#contributor0"}, "forenameInitials": "N"}, {"contributor": {"type": "Practitioner", "display": "Peneau M", "reference": "#contributor1"}, "forenameInitials": "M"}, {"contributor": {"type": "Practitioner", "display": "Mazeron JJ", "reference": "#contributor2"}, "forenameInitials": "JJ"}, {"contributor": {"type": "Practitioner", "display": "Molinie V", "reference": "#contributor3"}, "forenameInitials": "V"}, {"contributor": {"type": "Practitioner", "display": "Richaud P", "reference": "#contributor4"}, "forenameInitials": "P"}], "complete": true}, "publicationForm": [{"issue": "2", "volume": "62", "pageString": "213-9", "articleDate": "2012-08", "citedMedium": {"coding": [{"code": "internet", "system": "http://terminology.hl7.org/CodeSystem/cited-medium", "display": "Internet"}]}, "publishedIn": {"type": {"coding": [{"code": "D020492", "system": "http://terminology.hl7.org/CodeSystem/published-in-type", "display": "Periodical"}]}, "title": "European urology", "identifier": [{"type": {"text": "Electronic ISSN Type", "coding": [{"code": "Electronic", "system": "https://www.nlm.nih.gov/bsd/licensee/elements_descriptions.html#issn", "display": "Electronic"}]}, "value": "1873-7560", "system": "https://portal.issn.org"}, {"type": {"text": "ISOAbbreviation", "coding": [{"system": "http://terminology.hl7.org/CodeSystem/v2-0203", "code": "XX", "display": "Organization identifier"}]}, "value": "Eur Urol", "system": "https://www.issn.org/services/online-services/access-to-the-ltwa/"}, {"type": {"text": "ISSN Linking", "coding": [{"system": "http://terminology.hl7.org/CodeSystem/v2-0203", "code": "XX", "display": "Organization identifier"}]}, "value": "0302-2838", "system": "https://www.issn.org/understanding-the-issn/assignment-rules/the-issn-l-for-publications-on-multiple-media/"}, {"type": {"text": "Medline Title Abbreviation", "coding": [{"system": "http://terminology.hl7.org/CodeSystem/v2-0203", "code": "XX", "display": "Organization identifier"}]}, "value": "Eur Urol", "system": "https://www.nlm.nih.gov/tsd/cataloging/contructitleabbre.html"}, {"type": {"text": "NLM Unique ID", "coding": [{"system": "http://terminology.hl7.org/CodeSystem/v2-0203", "code": "XX", "display": "Organization identifier"}]}, "value": "7512719", "system": "https://locatorplus.gov/cgi-bin/Pwebrecon.cgi?DB=local"}], "publisherLocation": "Switzerland"}}, {"articleDate": "2012-04-03", "citedMedium": {"coding": [{"code": "internet-without-issue", "system": "http://terminology.hl7.org/CodeSystem/cited-medium", "display": "Internet without issue"}]}}]}, "classification": [{"type": {"coding": [{"code": "citation-source", "system": "http://terminology.hl7.org/CodeSystem/citation-classification-type", "display": "Citation Source"}]}, "classifier": [{"text": "MEDLINE"}]}, {"type": {"coding": [{"code": "medline-owner", "system": "http://terminology.hl7.org/CodeSystem/citation-classification-type", "display": "MEDLINE Citation Owner"}]}, "classifier": [{"coding": [{"code": "NLM", "system": "https://www.nlm.nih.gov/bsd/licensee/elements_descriptions.html#owner_value", "display": "National Library of Medicine, Index Section", "userSelected": false}]}]}], "lastReviewDate": "2022-03-10", "description": "This Citation Resource is referenced in an example for the EBMonFHIR Implementation Guide."}